Nadifloxacin downmodulates antigen-presenting functions of epidermal Langerhans cells and keratinocytes

Journal of Dermatological Science

Volumn 42, Issue 2, 2006, Pages 91-99

  Murata, Koji ^a   Sugita, Kazunari ^a   Kobayashi, Miwa ^a   Kabashima, Kenji ^a   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Antigen presenting cell; Keratinocyte; Langerhans cell; Nadifloxacin; T cell

Indexed keywords

ERYTHROMYCIN; HAPTEN; LEVOFLOXACIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NADIFLOXACIN; SUPERANTIGEN; TRINITROPHENYLHAPTEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CHEMICAL MODIFICATION; COCULTURE; CONTROLLED STUDY; DERIVATIZATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOREGULATION; KERATINOCYTE; LANGERHANS CELL; LYMPH NODE CELL; LYMPHOCYTE CULTURE; MOUSE; NEWBORN; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; FLOW CYTOMETRY; FLUOROQUINOLONES; INFLAMMATION; KERATINOCYTES; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; QUINOLIZINES;

EID: 33646035500     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2005.12.008     Document Type: Article

References (25)

1. Kersey P., Sussman M., and Dahl M. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris. Br J Dermatol 103 (1980) 651-655
2. Webster G.F. Inflammatory acne represents hypersensitivity to Propionibacterium acnes. Dermatology 196 (1998) 80-81
3. Norris J.F., and Cunliffe W.J. A histological and immunocytochemical study of early acne lesions. Br J Dermatol 118 (1988) 651-659
4. Jeremy A.H., Holland D.B., Roberts S.G., Thomson K.F., and Cunliffe W.J. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121 (2003) 20-27
5. Holland D.B., Jeremy A.H., Roberts S.G., Seukeran D.C., Layton A.M., and Cunliffe W.J. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol 150 (2004) 72-81
6. Kreuter A., Schlottmann R., Altmeyer P., and Brockmeyer N.H. Acne vulgaris as an immune reconstitution syndrome in a patient with AIDS after initiation of antiretroviral therapy. J Eur Acad Dermatol Venereol 16 (2002) 638
7. Layton A.M., Morris C., Cunliffe W.J., and Ingham E. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol 7 (1998) 191-197
8. Koreck A., Pivarcsi A., Dobozy A., and Kemeny L. The role of innate immunity in the pathogenesis of acne. Dermatology 206 (2003) 96-105
9. Vowels B.R., Yang S., and Leyden J.J. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63 (1995) 3158-3165
10. Kim J., Ochoa M.T., Krutzik S.R., Takeuchi O., Uematsu S., Legaspi A.J., et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169 (2002) 1535-1541
11. Ishikawa H., Tabusa F., Miyamoto H., Kano M., Ueda H., Tamaoka H., et al. Studies on antibacterial agents. I. Synthesis of substituted 6,7-dihydro-1-oxo-1H, 5H-benzo[i, j]quinolizine-2-carboxylic acids. Chem Pharm Bull (Tokyo) 37 (1989) 2103-2108
12. Akamatsu H., Sasaki H., Kurokawa I., Nishijima S., Asada Y., and Niwa Y. Effect of nadifloxacin on neutrophil functions. J Int Med Res 23 (1995) 19-26
13. Kuwahara K., Kitazawa T., Kitagaki H., Tsukamoto T., and Kikuchi M. Nadifloxacin an antiacne wuinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci 38 (2005) 47-55
14. Streilein J.W., and Bergstresser P.R. Langerhans cells: antigen presenting cells of the epidermis. Immunobiology 168 (1984) 285-300
15. Enk A.H., and Katz S.I. Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol 105 (1995) S80-S83
16. Tokura Y., Yagi J., O'Malley M., Lewis J.M., Takigawa M., Edelson R.L., et al. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of angerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 102 (1994) 31-38
17. Tokura Y., Yagi H., Hashizume H., Yagi J., Furukawa F., and Takigawa M. Accessory cell ability of Langerhans cells for superantigen is resistant to ultraviolet-B light. Photochem Photobiol 60 (1994) 147-153
18. Wakita H., Tokura Y., Furukawa F., and Takigawa M. The macrolide antibiotic, roxithromycin suppresses IFN-γ-mediated immunological functions of culture normal human keratinocytes. Biol Pharm Bull 19 (1996) 224-227
19. Tokura Y., Seo N., Yagi H., Furukawa F., and Takigawa M. Cross-reactivity in murine fluoroquinolone photoallergy: exclusive usage of TCR Vβ13 by immune T cells that recognize fluoroquinolone-photomodified cells. J Immunol 160 (1998) 3719-3728
20. Araujo F.G., Slifer T.L., and Remington J.S. Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. Clin Microbiol Infect 8 (2002) 26-30
21. Riesbeck K. Immunomodulating activity of quinolones: review. J Chemother 14 (2002) 3-12
22. Pessina A., Raimondi A., Cerri A., Piccirillo M., Neri M.G., Croera C., et al. High sensitivity of human epidermal keratinocytes (HaCaT) to topoisomerase inhibitors. Cell Prolif 34 (2001) 243-252
23. Watanabe H., Unger M., Tuvel B., Wang B., and Sauder D.N. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res 22 (2002) 407-412
24. Balato N., Lembo G., Cuccurullo F.M., Patruno C., Nappa P., and Ayala F. Acne and allergic contact dermatitis. Contact Dermatitis 34 (1996) 68-69
25. Williams R.E., Doherty V.R., Perkins W., Aitchison T.C., and Mackie R.M. Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol 126 (1992) 362-366